Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research

Molecular Human Reproduction

Volumn 15, Issue 11, 2009, Pages 703-711

  Rahman, Nafis A ^a,b   Rao, C V ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Gonadal and nongonadal effects; Human chorionic gonadotrophin; Human chorionic gonadotrophin receptor; Luteinizing; Luteinizing hormone

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN DERIVATIVE; HECATE CHORIONIC GONADOTROPHIN BETA CONJUGATE LYTIC PEPTIDE; LUTEINIZING HORMONE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; ENDOCRINE TUMOR; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFERTILITY THERAPY; NONHUMAN; OVARY FOLLICLE MATURATION; OVULATION; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; SPONTANEOUS ABORTION; TREATMENT INDICATION; BLOOD; FEMALE; MALE; METABOLISM; OVULATION INDUCTION; PHYSIOLOGY; REVIEW;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; LUTEINIZING HORMONE; MALE; OVULATION INDUCTION; REPRODUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 74049117606     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gap067     Document Type: Article

References (107)

1. Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E, Rao Ch V. Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors. J Clin Endocrinol Metab 2004;89:952-956.
2. Ahtiainen P, Rulli S, Pakarainen T, Zhang FP, Poutanen M, Huhtaniemi I. Phenotypic characterisation of mice with exaggerated and missing LH/hCG action. Mol Cell Endocrinol 2007;260-262:255-263.
3. Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G. Outlook: who needs LH in ovarian stimulation? Reprod Biomed Online 2006;12:599-607.
4. Apaja PM, Aatsinki JT, Rajaniemi HJ, Petaja-Repo UE. Expression of the mature luteinizing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a posttranslational level. Endocrinology 2005;146:3224-3232.
5. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 2002;23:141-174.
6. Atwood CS, Meethal SV, Liu T, Wilson AC, Gallego M, Smith MA, Bowen RL. Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J Neuropathol Exp Neurol 2005;64:93-103.
7. Barron AM, Verdile G, Martins RN. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms. Endocrine 2006;29:257-269.
8. Barron AM, Taddei K, Verdile G, Martins RN. Human chorionic gonadotropin increases exploratory behaviour and impairs episodic-like memory in PS1M146V mice. Neurosci Res 2007;58:62-67.
9. Belmonte A, Ticconi C, Dolci S, Giorgi M, Zicari A, Lenzi A, Jannini EA, Piccione E. Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin. J Soc Gynecol Investig 2005;12:570-577.
10. Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005;308:1587-1589.
11. Berndt S, Perrier d'Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, Applanat M, Herve MA, Lamande N, Corvol P et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J 2006;20:2630-2632.
12. Bodek G, Rahman NA, Zaleska M, Soliymani R, Lankinen H, Hansel W, Huhtaniemi I, Ziecik AJ. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate. Breast Cancer Res Treat 2003;79:1-10.
13. Bodek G, Kowalczyk A, Waclawik A, Huhtaniemi I, Ziecik AJ. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway. Exp Biol Med (Maywood) 2005a; 230:421-428.
14. Bodek G, Vierre S, Rivero-Muller A, Huhtaniemi I, Ziecik AJ, Rahman NA. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice. Neoplasia 2005b; 7:497-508.
15. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, Martins RN, Atwood CS. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem 2004;279:20539-20545.
16. Casadesus G, Atwood CS, Zhu X, Hartzler AW, Webber KM, Perry G, Bowen RL, Smith MA. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell Mol Life Sci 2005;62:293-298.
17. Chudgar D, Lei Z, Rao Ch V. Orthotopic transplantation of LH receptor knockout and wild-type ovaries. Life Sci 2005;77:2656-2662.
18. Dabizzi S, Noci I, Borri P, Borrani E, Giachi M, Balzi M, Taddei GL, Marchionni M, Scarselli GF, Arcangeli A. Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A. Cancer Res 2003;63:4281-4286.
19. Davies S, Bax CM, Chatzaki E, Chard T, Iles RK. Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br J Cancer 2000;83:1730-1734.
20. Davies S, Byrn F, Cole LA. Human chorionic gonadotropin testing for early pregnancy viability and complications. Clin Lab Med 2003;23:257-264, vii.
21. Dawood MY. Corpus luteal insufficiency. Curr Opin Obstet Gynecol 1994;6:121-127.
22. De SK, Devadas K, Notkins AL. Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha. J Virol 2002;76:11710-11714.
23. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-396.
24. Dufau ML. The luteinizing hormone receptor. Annu Rev Physiol 1998;60:461-496.
25. Eblen A, Bao S, Lei ZM, Nakajima ST, Rao CV. The presence of functional luteinizing hormone/chorionic gonadotropin receptors in human sperm. J Clin Endocrinol Metab 2001;86:2643-2648.
26. Filicori M, Fazleabas AT, Huhtaniemi I, Licht P, Rao Ch V, Tesarik J, Zygmunt M. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril 2005;84:275-284.
27. Fujimoto A, Osuga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M, Kugu K, Koga K, Morita Y, Wada O et al. Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet 2002;19:550-554.
28. Gawronska B, Leuschner C, Enright FM, Hansel W. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo. Gynecol Oncol 2002;85:45-52.
29. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
30. Han SW, Lei ZM, Rao CV. Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology 1996; 137:1791-1797.
31. Han SW, Lei ZM, Rao CV. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells. Biol Reprod 1997;57:158-164.
32. Hansel W, Leuschner C, Gawronska B, Enright F. Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates. Reprod Biol 2001;1:20-32.
33. Huber AV, Huber JC, Kolbus A, Imhof M, Nagele F, Loizou D, Kaufmann U, Singer CF. Systemic HCG treatment in patients with endometriosis: a new perspective for a painful disease. Wien Klin Wochenschr 2004;116:839-843.
34. Huber A, Hudelist G, Knofler M, Saleh L, Huber JC, Singer CF. Effect of highly purified human chorionic gonadotropin preparations on the gene expression signature of stromal cells derived from endometriotic lesions: potential mechanisms for the therapeutic effect of human chorionic gonadotropin in vivo. Fertil Steril 2007;88:1232-1239.
35. Huddleston HG, Jackson KV, Doyle JO, Racowsky C. hMG increases the yield of mature oocytes and excellent-quality embryos in patients with a previous cycle having a high incidence of oocyte immaturity. Fertil Steril 2009. April 6. [Epub ahead of print].
36. Huhtaniemi I, Pelliniemi LJ. Fetal Leydig cells: cellular origin, morphology, life span, and special functional features. Proc Soc Exp Biol Med 1992;201:125-140.
37. Huhtaniemi IT, Korenbrot CC, Jaffe RB. HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 1977;44:963-967.
38. Kafy S, Tulandi T. New advances in ovulation induction. Curr Opin Obstet Gynecol 2007;19:248-252.
39. Kananen K, Markkula M, El-Hefnawy T, Zhang FP, Paukku T, Su JG, Hsueh AJ, Huhtaniemi I. The mouse inhibin alpha-subunit promoter directs SV40 T-antigen to Leydig cells in transgenic mice. Mol Cell Endocrinol 1996;119:135-146.
40. Kananen K, Rilianawati, Paukku T, Markkula M, Rainio EM, Huhtanemi I. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. Endocrinology 1997;138:3521-3531.
41. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 2000;105:633-641.
42. Kiiveri S, Siltanen S, Rahman N, Bielinska M, Lehto VP, Huhtaniemi IT, Muglia LJ, Wilson DB, Heikinheimo M. Reciprocal changes in the expression of transcription factors GATA-4 and GATA-6 accompany adrenocortical tumorigenesis in mice and humans. Mol Med 1999; 5:490-501.
43. Konishi I, Koshiyama M, Mandai M, Kuroda H, Yamamoto S, Nanbu K, Komatsu T, Matsushita K, Rao CV, Mori T. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol 1997;65:273-280.
44. Kurtzman JT, Spinnato JA, Goldsmith LJ, Zimmerman MJ, Klem M, Lei ZM, Rao CV. Human chorionic gonadotropin exhibits potent inhibition of preterm delivery in a small animal model. Am J Obstet Gynecol 1999; 181:853-857.
45. Kurtzman JT, Wilson H, Rao CV. A proposed role for hCG in clinical obstetrics. Semin Reprod Med 2001;19:63-68.
46. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-461.
47. Lei ZM, Rao CV. Protective Role of Human Chorionic Gonadotropin and Luteinizing Hormone against Breast Cancer. London: Springer-Verlag, 2000.
48. Lei ZM, Rao CV. Endocrinology of the trophoblast tissue. In: Becker KL (ed). Principles and Practice of Endocrinology and Metabolism. Philadelphia, PA: Lippincott Williams & Wilkins, 2001a, 1096-1102.
49. Lei ZM, Rao CV. Neural actions of luteinizing hormone and human chorionic gonadotropin. Semin Reprod Med 2001b;19:103-109.
50. Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology 1993a;132:2262-2270.
51. Lei ZM, Toth P, Rao CV, Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 1993b;77:863-872.
52. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, Rao CV. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 2001;15:184-200.
53. Leuschner C, Hansel W. Membrane disrupting lytic peptides for cancer treatments. Curr Pharm Des 2004;10:2299-2310.
54. Leuschner C, Enright FM, Melrose PA, Hansel W. Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors. Prostate 2001;46:116-125.
55. Leuschner C, Enright FM, Gawronska B, Hansel W. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo. Breast Cancer Res Treat 2003a; 78:17-27.
56. Leuschner C, Enright FM, Gawronska-Kozak B, Hansel W. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors. Prostate 2003b;56:239-249.
57. Lin J, Lei ZM, Lojun S, Rao CV, Satyaswaroop PG, Day TG. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 1994;79:1483-1491.
58. Lin PC, Li X, Lei ZM, Rao Ch V. Human cervix contains functional luteinizing hormone/human chorionic gonadotropin receptors. J Clin Endocrinol Metab 2003;88:3409-3414.
59. Lin DX, Lei ZM, Li X, Rao ChV. Targeted disruption of LH receptor gene revealed the importance of uterine LH signaling. Mol Cell Endocrinol 2005a;234:105-116.
60. Lin DX, Lei ZM, Rao ChV. Dependence of uterine cyclooxygenase2 expression on luteinizing hormone signaling. Biol Reprod 2005b; 73:256-260.
61. Lincoln SR, Lei ZM, Rao CV, Yussman MA. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in ectopic human endometrial implants. J Clin Endocrinol Metab 1992; 75:1140-1144.
62. Lojun S, Bao S, Lei ZM, Rao CV. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer. Biol Reprod 1997;57:1202-1210.
63. Lopez D, Sekharam M, Coppola D, Carter WB. Purified human chorionic gonadotropin induces apoptosis in breast cancer. Mol Cancer Ther 2008;7:2837-2844.
64. Matheson PB, Weedon J, Cappelli M, Abrams EJ, Shaffer N, Bamji M, Krasinski K, Lambert G, Kaul A, Grimm K et al. Comparison of methods of estimating the mother-to-child transmission rate of human immunodeficiency virus type 1 (HIV-1). New York City Perinatal HIV Transmission Collaborative Study Group. Am J Epidemiol 1995; 142:714-718.
65. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992; 360:313-319.
66. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A 1994;91:8817-8821.
67. McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, Segaloff DL, Seeburg PH. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science 1989;245:494-499.
68. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997;57:857-864.
69. Meethal SV, Smith MA, Bowen RL, Atwood CS. The gonadotropin connection in Alzheimer's disease. Endocrine 2005;26:317-326.
70. Morbeck DE, Roche PC, Keutmann HT, McCormick DJ. A receptor binding site identified in the region 81-95 of the beta-subunit of human luteinizing hormone (LH) and chorionic gonadotropin (hCG). Mol Cell Endocrinol 1993;97:173-181.
71. Nagamani M, Doherty MG, Smith ER, Chandrasekhar Y. Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancer. Am J Obstet Gynecol 1992;167:1825-1830.
72. Nyboeandersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsboll S, Rasmussen PE, Lindenberg S, Bredkjaer HE, Meinertz H. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 2008; 23:427-434.
73. Pabon JE, Bird JS, Li X, Huang ZH, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Human skin contains luteinizing hormone/chorionic gonadotropin receptors. J Clin Endocrinol Metab 1996a;81:2738-2741.
74. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 1996b;81:2397-2400.
75. Pakarainen T, Zhang FP, Poutanen M, Huhtaniemi I. Fertility in luteinizing hormone receptor-knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal luteinizing hormone action. J Clin Invest 2005;115:1862-1868.
76. Pakarainen T, Ahtiainen P, Zhang FP, Rulli S, Poutanen M, Huhtaniemi I. Extragonadal LH/hCG action-not yet time to rewrite textbooks. Mol Cell Endocrinol 2007;269:9-16.
77. Phillips RJ, Tyson-Capper Nee Pollard AJ, Bailey J, Robson SC, Europe-Finner GN. Regulation of expression of the chorionic gonadotropin/luteinizing hormone receptor gene in the human myometrium: involvement of specificity protein-1 (Sp1), Sp3, Sp4, Sp-like proteins, and histone deacetylases. J Clin Endocrinol Metab 2005;90:3479-3490.
78. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem 1981;50:465-495.
79. Polliotti BM, Gnall-Sazenski S, Laughlin TS, Miller RK. Inhibitory effects of human chorionic gonadotropin (hCG) preparations on HIV infection of human placenta in vitro. Placenta 2002;23(Suppl. A):S102-S106.
80. Rahman NA, Huhtaniemi IT. Ovarian tumorigenesis in mice transgenic for murine inhibin alpha subunit promoter-driven Simian Virus 40 T-antigen: ontogeny, functional characteristics, and endocrine effects. Biol Reprod 2001;164:1122-1130.
81. Rahman NA, Kiiveri S, Rivero-Muller A, Levallet J, Vierre S, Kero J, Wilson DB, Heikinheimo M, Huhtaniemi I. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4. Mol Endocrinol 2004;18:2553-2569.
82. Rao CV. Differential properties of human chorionic gonadotrophin and human luteinizing hormone binding to plasma membranes of bovine corpora lutea. Acta Endocrinol (Copenh) 1979;90:696-710.
83. Rao CV. Tropic effects of LH and hCG on early pregnancy events in women's reproductive tract. Early Pregnancy 2001;5:18-19.
84. Rao CV, Lei ZM. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol 2007;269:2-8.
85. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 1990;70:421-430.
86. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 1995;92:1322-1326.
87. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 2002; 143:4084-4095.
88. Rulli SB, Ahtiainen P, Makela S, Toppari J, Poutanen M, Huhtaniemi I. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology 2003;144:4980-4990.
89. Russo IH, Russo J. Physiological bases of breast cancer prevention. Eur J Cancer Prev 1993;2(Suppl. 3):101-111.
90. Russo IH, Koszalka M, Gimotty PA, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 1990a;62:243-247.
91. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 1990b; 11:1849-1855.
92. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 1990c;82:1286-1289.
93. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990d;62:244-278.
94. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992;23:211-218.
95. Segaloff DL, Ascoli M. The lutropin/choriogonadotropin receptor...4 years later. Endocr Rev 1993;14:324-347.
96. Slattery MM, Brennan C, O'Leary MJ, Morrison JJ. Human chorionic gonadotrophin inhibition of pregnant human myometrial contractility. BJOG 2001;108:704-708.
97. Tao YX, Bao S, Ackermann DM, Lei ZM, Rao CV. Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans. Biol Reprod 1997a;56:67-72.
98. Tao YX, Lei ZM, Rao CV. The presence of luteinizing hormone/human chorionic gonadotropin receptors in lactating rat mammary glands. Life Sci 1997b;60:1297-1303.
99. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002; 17:3129-3137.
100. Tesarik J, Hazout A, Mendoza C. Luteinizing hormone affects uterine receptivity independently of ovarian function. Reprod Biomed Online 2003;7:59-64.
101. Than NG, Itakura A, Rao CV, Nohira T, Toth P, Mansell JP, Isaka K, Nishi H, Takayama M, Than GN. Clinical applications of pregnancy-related-protein-a workshop report. Placenta 2003; 24:60-64.
102. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, Rao CV. Clinical importance of vascular LH/hCG receptors-a review. Reprod Biol 2001;1:5-11.
103. Vuorenoja S, Rivero-Muller A, Ziecik AJ, Huhtaniemi I, Toppari J, Rahman NA. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate. Endocr Relat Cancer 2008; 15:635-648.
104. Vuorenoja S, Mohanty B, Arola J, Huhtaniemi I, Toppari J, Rahman N. Hecate-CG{beta} conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin {alpha} promoter. Endocr Relat Cancer 2009;16:549-564.
105. Yarram SJ, Perry MJ, Christopher TJ, Westby K, Brown NL, Lamminen T, Rulli SB, Zhang FP, Huhtaniemi I, Sandy JR et al. Luteinizing hormone receptor knockout (LuRKO) mice and transgenic human chorionic gonadotropin (hCG)-overexpressing mice (hCG alphabeta+) have bone phenotypes. Endocrinology 2003;144:3555-3564.
106. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001a;15: 172-183.
107. Zhang M, Shi H, Segaloff DL, Van Voorhis BJ. Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod 2001b;64:179-187.